Interest in Treatment with GLP-1 Receptor Agonists for the Management of Insufficient Weight Loss or Weight Regain After Bariatric Surgery
arGLP-1 are effective and safe for managing IWL or WR after BS, leading to significant weight loss, comorbidity improvement, and sustained %TWL. These findings support their use as a valuable adjunctive obesity management medication (OMMs) in post-bariatric care, though long-term adherence and cost-effectiveness require further investigation.
Authors
- Joseph Derienne (ORCID: https://orcid.org/0000-0002-2562-6507)
- Hadrien Tranchart (ORCID: https://orcid.org/0000-0003-2173-2828)
- Rodi Courie
- Cosmin Sebastian Voican (ORCID: https://orcid.org/0000-0002-7161-9631)
- Gabriel Perlemuter (ORCID: https://orcid.org/0000-0001-9985-8725)
- Hussein Abdallah (ORCID: https://orcid.org/0000-0002-0358-852X)
- Ibrahim Dagher
- Wissam Hadi Klink
Institutions
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Antoine-Béclère (FR)
Publication Details
- Journal
- Obesity Surgery
- Published
- 2025-09-05
- DOI
- https://doi.org/10.1007/s11695-025-08210-y
- Citations
- 6
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 12.04
Funders
- Université Paris-Saclay